Donna Oksenberg

Donna Oksenberg

UNVERIFIED PROFILE

Are you Donna Oksenberg?   Register this Author

Register author
Donna Oksenberg

Donna Oksenberg

Publications by authors named "Donna Oksenberg"

Are you Donna Oksenberg?   Register this Author

17Publications

386Reads

13Profile Views

GBT440 improves red blood cell deformability and reduces viscosity of sickle cell blood under deoxygenated conditions.

Clin Hemorheol Microcirc 2018 ;70(1):95-105

Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CH-170340DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996409PMC
November 2018

GBT440 reverses sickling of sickled red blood cells under hypoxic conditions .

Hematol Rep 2018 May 14;10(2):7419. Epub 2018 May 14.

Global Blood Therapeutics Inc., South San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2018.7419DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036981PMC
May 2018

GBT1118, a potent allosteric modifier of hemoglobin O affinity, increases tolerance to severe hypoxia in mice.

Am J Physiol Heart Circ Physiol 2017 Aug 19;313(2):H381-H391. Epub 2017 May 19.

Department of Bioengineering, University of California-San Diego, La Jolla, California

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpheart.00772.2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582925PMC
August 2017

GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease.

Br J Haematol 2016 10 5;175(1):141-53. Epub 2016 Jul 5.

Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University School of Medicine, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14214DOI Listing
October 2016

GBT440 Inhibits Sickling of Sickle Cell Trait Blood Under Conditions Mimicking Strenuous Exercise.

Hematol Rep 2016 Sep 28;8(3):6637. Epub 2016 Sep 28.

Global Blood Therapeutics Inc. , San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2016.6637DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062624PMC
September 2016

A pharmacological screening approach for discovery of neuroprotective compounds in ischemic stroke.

PLoS One 2013 18;8(7):e69233. Epub 2013 Jul 18.

Behavioral and Functional Neuroscience Laboratory, Institute for Neuro-Innovation and Translational Neurosciences, School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0069233PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715457PMC
February 2014

Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP).

Eur J Neurosci 2006 Jun;23(11):2847-56

AGY Therapeutics Inc, 270 E. Grand Avenue, South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1460-9568.2006.04837.xDOI Listing
June 2006

Death-associated protein kinase is activated by dephosphorylation in response to cerebral ischemia.

J Biol Chem 2005 Dec 3;280(51):42290-9. Epub 2005 Oct 3.

AGY Therapeutics, Inc., South San Francisco, California 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M505804200DOI Listing
December 2005

A high-throughput turbidometric assay for screening inhibitors of protein disulfide isomerase activity.

J Biomol Screen 2004 Oct;9(7):614-20

Lead Discovery Department, AGY Therapeutics Inc, South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057104265292DOI Listing
October 2004